About Amir Abolfathi
Amir Abolfathi is executive chairman of MaxQ Medical and of NFTR Technologies. He also sits on the boards of BRIUS, the maker of Brava braces, and R3 Vascular. Since 2025 he has been a director of the American Dental Association's ADA Corporate Ventures.
He co-founded uLab Systems and was its CEO from 2020. Before that he was CEO of Tusker Medical and of Sonitus Medical. From 1999 to 2004 he worked at Align Technology, the maker of Invisalign, first as senior director of planning and then as vice president of research and development. Earlier he co-founded EndoTex Interventional Systems, where he led research and development from 1995 to 1999, and he worked at Pfizer, Guidant and Baxter-Edwards.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Amir Abolfathi in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Amir Abolfathi works with at each company, as listed on that company's latest Form D.
Amir Abolfathi in the News
- MaxQ Medical Raises $31.5 Million Series A, Backed by Olympus, to Advance its Prostate Care Platform
- uLab Enables Direct-to-Patient Shipments for uSmile Retainers
- uLab Systems Offers Orthodontists New Pricing Structure for Aligners
- CMS Killed My $80M Venture-Backed Startup
- SoundBite In-the-Mouth Hearing System Is FDA Cleared for Single-Sided Deafness
Sources
- SECMaxQ Medical Inc. Form D, filed Aug 19, 2026
- SECBRIUS Technologies, Inc. Form D, filed Jul 23, 2026
- SECVentaris Surgical, Inc. Form D, filed Mar 2, 2026
- SECR3 Vascular Inc. Form D, filed Sep 12, 2024
- Company siteNFTR Technologies: Board of Directors page
- Press releaseAmerican Dental Association: ADA Corporate Ventures welcomes three new board members, July 2, 2025
- Company press releaseuLab Systems announces CEO and CFO, July 7, 2020
- Company press releaseuLab Systems: Inc. 5000 release, August 18, 2022 (Amir Abolfathi, chief executive officer and co-founder)
- SEC filingAlign Technology 10-K for 2003 (executive officer biography)
- SEC filingAlign Technology 8-K exhibit 99.1, November 10, 2004 (Abolfathi resigns as Vice President of Research and Development)
- Company press releaseiT2 launch release, October 5, 2021 (Sonitus Technologies spun out of Sonitus Medical)
- Company press releaseVentaris Surgical Series A release, January 9, 2026 ('independent board member Amir Abolfathi')